Raymond James initiated coverage on Accolade Inc (NASDAQ: ACCD) with an Outperform rating and a $15 price target. Employers have increasingly added disconnected point solutions, which are generally under-used, lack a common IT platform, and have further convoluted an already-complex ecosystem, writes the analyst. Related: Analysts Stay Bullish On Accolade Stock, Call Q3 Earnings Better Than Expected Amid Challenging Backdrop. Accolade integrates an employer’s health benefits into a unified platf
Accolade, Inc. ( NASDAQ:ACCD ) insiders who purchased shares in the last 12 months were richly rewarded last week. The...
Blue Shield of California today unveiled its Virtual Blue health benefits plan offering members easy-to-access, comprehensive care through a team of "virtual-first" primary, behavioral, and specialist healthcare professionals.